https://actionforat.org/wp-content/uploads/2024/09/2023_03_13-Samuel-M-Young-Jr.-klaird-005-PIC-scaled.jpg
2560
2048
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-09-17 13:24:182024-09-17 13:24:18Development of a Gene Therapy approach to treat A-T
https://actionforat.org/wp-content/uploads/2020/07/Robert-Dineen.jpg
1186
1246
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-09-16 10:54:582024-10-09 14:39:23Biomarkers for Babies and Young Children with Ataxia Telangiectasia (BOBCAT)
https://actionforat.org/wp-content/uploads/2024/09/Richard-Tuxworth-0620-scaled.jpg
2560
1920
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-09-16 10:09:372024-10-09 14:55:20Identifying existing drugs to repurpose for treating Ataxia-Telangiectasia
https://actionforat.org/wp-content/uploads/2024/09/PaolaGiunti.jpg
606
756
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-09-16 09:00:462024-09-16 12:25:23Exploring Omaveloxolone efficacy in Ataxia-telangiectasia
https://actionforat.org/wp-content/uploads/2024/08/Mirjam-van-der-Burg-pic-scaled-e1724068718352.jpg
1920
1706
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-08-19 12:57:062024-09-16 10:42:13Functional impact of Nicotinamide Riboside on the immune system of patients with A-T
https://actionforat.org/wp-content/uploads/2024/06/Picture-Zoya-Ignatova.jpg
1080
1600
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-06-14 15:37:432024-08-21 14:28:56Development of suppressor tRNA-based therapeutics
https://actionforat.org/wp-content/uploads/2024/01/Hilde-Loge-Nilsen-Oslo-University-Hospital-Norway-scaled-e1706089004538.jpg
381
400
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-01-24 09:39:312024-02-21 12:55:57Preclinical Assessment of Intrathecal rAAV9-Mediated miATM Therapy for Ataxia Telangiectasia in Mouse Models.
https://actionforat.org/wp-content/uploads/2024/01/Nuria-Montserrat-IBEC-Barcelona-Spain-cropped-e1706088205179.jpg
468
400
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-01-24 09:29:372024-01-24 10:35:15Modelling Ataxia Telangiectasia pathogenesis and therapeutics using human pluripotent stem cells and genetic engineering.
https://actionforat.org/wp-content/uploads/2023/02/esterno-costanzo043-IMG_7862.jpg
1181
1772
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2023-02-09 14:56:082023-07-19 10:42:25Understanding and correcting glucose metabolism defects in A-T
https://actionforat.org/wp-content/uploads/2022/11/Sam-Nayler-2022-scaled.jpg
1707
2560
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2022-11-23 10:55:072024-08-19 12:59:27Digital drug prediction informed by genetic analysis of stem cell-derived mini-brains from A-T patients
https://actionforat.org/wp-content/uploads/2022/11/Horvath-and-Hensiek-New.png
995
1328
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2022-11-21 12:22:282023-07-19 11:02:10Trial REadiness in Ataxia Telangiectasia (TREAT-AT)
https://actionforat.org/wp-content/uploads/2022/10/Desimio-MG-Doria-M.jpg
1130
1616
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2022-10-13 15:49:032023-11-20 14:35:46Study of natural killer cells in A-T pathogenesis and their therapeutic implications
https://actionforat.org/wp-content/uploads/2018/12/James-Dixon-Square-e1545064705987.jpg
280
300
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2022-08-26 08:54:592024-10-10 14:03:49Brain-penetrating ATM gene therapy
https://actionforat.org/wp-content/uploads/2017/12/Prof-Yanez-e1641913699629.jpg
299
300
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2021-03-12 14:05:172024-02-26 14:23:37Further development of CRISPR/Cas Genome Editing as a Treatment for Ataxia Telangiectasia
https://actionforat.org/wp-content/uploads/2020/01/Photograph_Munira.jpg
4032
3024
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2020-01-28 11:34:222024-01-23 14:42:06The ATeam: Producing healthcare guidance for children with A-T including the exploration and design of a home-based exercise package
